JMP Securities analyst Jason Butler has reiterated their bullish stance on IRWD stock, giving a Buy rating yesterday. Jason Butler has given his Buy rating due to a combination of factors including ...

Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Ironwood Pharma (IRWD – Research Report) today. The company’s shares closed yesterday at $1.52. See what stocks are receiving Strong ...

Jefferies initiated coverage of Ironwood Pharmaceuticals (NASDAQ:IRWD) with a buy rating, stating that it believes the Street is underappreciating the potential upside from its GLP-2 agonist drug ...

StockNews.com upgraded shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) from a hold rating to a buy rating in a research report report published on Saturday. IRWD has been the subject of ...

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) is one of the cheap hot stocks to invest in right now. On January 5, Craig-Hallum upgraded Ironwood to Buy from Hold and increased the price target to $5.70 ...